Qualigen Therapeutics stockholders approve all proposals with majority vote

Qualigen Therapeutics (QLGN) announced the certified voting results of its Special Meeting of Stockholders. All proposals passed with majority approval. As a result of the approved actions, Faraday Future (FFAI) is expected to become the Company’s majority and controlling shareholder with an estimated 55% direct equity ownership. Including affiliated stockholders such as YT Jia and Jerry Wang, this increases this amount to approximately 63%. Faraday Future will designate the majority of the reconstituted Board of Directors. Governance restructuring will be completed ahead of the Company’s planned public renaming on November 20 to support execution of the new strategic direction.